close

Вход

Забыли?

вход по аккаунту

?

код для вставки
2005
Receptor binding activity
X 0280
Identification of a 5-HT4 Receptor Antagonist Clinical Candidate Through
Side-Chain Modification. — Several novel derivatives of the initial clinical candidate
30- 210 sulamserod
such as (I) are synthesized by conventional procedures. Among them the
substance (Id) fulfills the criteria of a novel clinical candidate. The biological results
are discussed in detail. — (CLARK*, R. D.; et al.; Bioorg. Med. Chem. Lett. 15
(2005) 6, 1697-1700; Dep. Med. Chem., Roche, Palo Alto, CA 94303, USA; Eng.)
— K. Schneider
Документ
Категория
Без категории
Просмотров
0
Размер файла
12 Кб
Теги
1/--страниц
Пожаловаться на содержимое документа